Five-Year Management of Vascular Injuries of the Extremities in the “Real-World” Setting in Northeastern Greece: The Role of Iatrogenic Traumas

PERAN KAP DALAM IMPLEMENTASI KURIKULUM KAMPUS MERDEKA Imanta Tarigan [email protected] [email protected] Joachim Poltak Lian & RekanAli Masjono [email protected] Jurusan akutansi PNJ ABSTRACTThis qualitative research base on KAP Joachim Poltak Lian & Rekan experiences inconducting internship program with PNJ. The objective of the article is identify of probability ofexpanding internship program with PNJ by not only KAP but also other type of industries and also to identify the role of KAP in supporting Kampus Merdeka Curriculum. The result show, KAP plays a dominant role in supporting internship program where KAP has already started the supporting many students to learn and experiencing the real world. The curriculum has already support the need of KAP therefore, this link is possible to be expanded. Keywords: KAP Joachim Poltak Lian & Rekan, Internship, Kampus Merdeka, Kurikulum ABSTRAKArtikel ini merupakan hasil kajian dari pengalaman KAP Joachim Poltak Lian & Rekan danPoliteknik Negeri Jakarta dalam menjalankan program magang bagi mahasiswa. Tujuan dari kajian ini adalah untuk mengidentifikasi kemungkinan industri untuk berperan dalam implementasikurikulum kampus merdeka. Kajian ini dibuat dengan menggunakan metodologi kualitatip, dimana dalam pengolahannya melibatkan pihak KAP, PNJ, mahasiswa yang terlibat program magang yang dilakukan dalam satu fokus group discussion. Data dikumpulkan dari berbagai media dan sumber sumber resmi dari kementrian pendidikan dan kebudayaan dan diolah dengan menggunakan metode compare, contras dan sintesis. Hasilnya menyimpulkan bahwa kerja sama antara KAP dan PNJ telah mempelopori implementasi kurikulum kampus merdeka dan telah memberi manfaat bagi KAP, mahasiswa dan PNJ. Kata kunci: KAP Joachim Poltak Lian & Rekan, Internship, Kampus Merdeka, Currikulum

Download Full-text

Trends in Chemotherapy Patterns and Survival of Patients with Advanced Gastric Cancer Over a 16-year Period: Impact of Anti-HER2-Targeted Agent in the Real-World Setting

Cancer Research and Treatment ◽

10.4143/crt.2020.725 ◽

2020 ◽

Author(s):

Dong-Hoe Koo ◽

Min-Hee Ryu ◽

Mi-Yeon Lee ◽

Heejung Chae ◽

Eo Jin Kim ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Real World ◽

The Real ◽

Real World Setting ◽

Targeted Agent

Download Full-text

The role of indexical cues in the distributional learning of phonetic categories.

10.31234/osf.io/zksaf ◽

2020 ◽

Author(s):

Carla L. Hudson Kam

Keyword(s):

Real World ◽

Speech Sounds ◽

The Real ◽

Distributional Learning ◽

Distributional Cues ◽

Phonetic Categories

Theories of the distributional learning of phonetic categories assume that input provides reliable distributional cues for the categorization of speech sounds. In the real world, however, not all talkers produce exactly the same distributions of speech sounds, and the talker-dependent variation may undermine the reliability of the distributional cues. In this study, we investigated how learners might overcome talker-dependent variation. Specifically, we tested whether adults can learn two phonetic categories from input in which talker-dependent variation introduces potential ambiguities into the categorization of speech sounds. The results suggest that they can overcome this kind of ambiguity by using indexical information (i.e., the identity of talkers).

Download Full-text

The Ethics of Regulation

Deakin Papers on International Business Economics ◽

10.21153/dpibe2010vol3no2art184 ◽

2010 ◽

Vol 3 (2) ◽

pp. 1-8

Author(s):

David Antoni ◽

Freddy Leal

Keyword(s):

Real World ◽

Regulatory Environment ◽

Trade Off ◽

The Real ◽

Ideal World ◽

Effi Ciency ◽

Self Interest ◽

Main Factors ◽

Regulatory Intervention

Regulations are often imposed in order to correct any failures in the market, whether the failure is a result of the functioning of a market or the behaviour of a government. However, every regulatory intervention br ings up a question: How ethical is the regulation? Even if a regulatory intervention could achieve more effici ency or more equity, it may not mean that it is ethi cal. The concept of ethics is ne cessarily subjective, it is based on the morals and standards of a society. Yet even though a society may be concerned about ethics, the issues of equity and altrui sm matter as does the way in which firms produce and seek to rationally an d efficiently maximize profit. Defining ethics is a difficul t issue, and defining ethical regu lation is even more difficult. Any form of regulation is a tool for interv ention used to balanc e the trade-off between efficiency and equity to create harmony between a market or economy and the society it functions within. In an ideal world, any go vernment intervention implemented would be for the greater benefit of all. However, this does not always happen in the vicissitudes of the real world when governments regulate an d intervene in markets, which are, in turn, based on the principle of rational self-interest and efficiency. In this paper we discuss the role of society in market regu lation. The discussion will focus on the importance of society on ethics and therefore on what constitutes ethical regulations. In fact we argue that equity, effi ciency or even failures are not the main factors to consider when regulating. It is society that defines ethics and how society understands ethics influences the regulatory environment

Download Full-text

Role of beta-blockers in patients admitted for worsening heart failure in a real world setting: data from the Italian Survey on Acute Heart Failure†

European Journal of Heart Failure ◽

10.1093/eurjhf/hfn008 ◽

2009 ◽

Vol 11 (1) ◽

pp. 77-84 ◽

Cited By ~ 10

Author(s):

Francesco Orso ◽

Samuele Baldasseroni ◽

Gianna Fabbri ◽

Lucio Gonzini ◽

Donata Lucci ◽

...

Keyword(s):

Heart Failure ◽

Acute Heart Failure ◽

Real World ◽

Beta Blockers ◽

Italian Survey ◽

Real World Setting

Download Full-text

Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2021-221915 ◽

2022 ◽

pp. annrheumdis-2021-221915

Author(s):

Farzin Khosrow-Khavar ◽

Seoyoung C Kim ◽

Hemin Lee ◽

Su Been Lee ◽

Rishi J Desai

Keyword(s):

Rheumatoid Arthritis ◽

Real World ◽

Fixed Effects ◽

Safety Concern ◽

Specific Effect ◽

Routine Care ◽

Cardiovascular Outcomes ◽

The Real ◽

Real World Setting ◽

Increased Risk

ObjectivesRecent results from ‘ORAL Surveillance’ trial have raised concerns regarding the cardiovascular safety of tofacitinib in patients with rheumatoid arthritis (RA). We further examined this safety concern in the real-world setting.MethodsWe created two cohorts of patients with RA initiating treatment with tofacitinib or tumour necrosis factor inhibitors (TNFI) using deidentified data from Optum Clinformatics (2012–2020), IBM MarketScan (2012–2018) and Medicare (parts A, B and D, 2012–2017) claims databases: (1) A ‘real-world evidence (RWE) cohort’ consisting of routine care patients and (2) A ‘randomised controlled trial (RCT)-duplicate cohort’ mimicking inclusion and exclusion criteria of the ORAL surveillance trial to calibrate results against the trial findings. Cox proportional hazards models with propensity score fine stratification weighting were used to estimate HR and 95% CIs for composite outcome of myocardial infarction and stroke and accounting for 76 potential confounders. Database-specific effect estimates were pooled using fixed effects models with inverse-variance weighting.ResultsIn the RWE cohort, 102 263 patients were identified of whom 12 852 (12.6%) initiated tofacitinib. The pooled weighted HR (95% CI) comparing tofacitinib with TNFI was 1.01 (0.83 to 1.23) in RWE cohort and 1.24 (0.90 to 1.69) in RCT-duplicate cohort which aligned closely with ORAL-surveillance results (HR: 1.33, 95% CI 0.91 to 1.94).ConclusionsWe did not find evidence for an increased risk of cardiovascular outcomes with tofacitinib in patients with RA treated in the real-world setting; however, tofacitinib was associated with an increased risk of cardiovascular outcomes, although statistically non-significant, in patients with RA with cardiovascular risk factors.Trial registration numberNCT04772248.

Download Full-text